SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Priv. Ord Regulatory News (CTPE)

Share Price Information for Ct Priv. Ord (CTPE)

Share Price is delayed by 15 minutes
Get Live Data
500.00    7.50 (1.53%)
Bid:
495.00
Ask:
500.00
Spread: 5.00 (1.01%)
Market Cap: £357.51m
CTPE Live PriceLast checked at - London Stock Exchange

Intraday Ct Priv. Ord Share Chart

Lead Fund Manager Succession

1 Dec 2025 07:00

RNS Number : 5165J
CT Private Equity Trust PLC
01 December 2025
 

To: RNS

From: CT Private Equity Trust PLC ("the Company")

Date: 1 December 2025

 

 

Lead Fund Manager Succession

 

The Board announces that at the conclusion of the Company's Annual General Meeting to be held in May 2026, Hamish Mair will retire from Columbia Threadneedle Investments and step down as the Company's Lead Fund Manager. Upon his retirement, Andrew Carnwath, the Company's Deputy Fund Manager will succeed Hamish as the Company's Lead Fund Manager, ensuring continuity and a smooth handover of responsibilities. Hamish will remain a senior adviser to Columbia Threadneedle Investments available to provide advice to the private equity investment team.

 

Andrew is currently the Company's Deputy Fund Manager. He has worked closely with Hamish Mair for 12 years, and has 17 years of private equity experience. He is a chartered accountant, CFA Charterholder and graduate of The University of Edinburgh.

 

Hamish Mair was instrumental in the creation of the Company in 1999, then known as Martin Currie Capital Return Trust PLC, and has been responsible for its management for the subsequent 26 years. An investor investing £100 at the inception of the Company and re-investing dividends, would now have £1,085, equivalent to a share price total return of 985% or 9.4% per annum. The NAV total return over the same period is 1,233% with an annualised return of 10.2%. The gains accumulated since the start of the Company equate to 12.3x the original investment. By comparison the stock market, as represented by the FTSE All Share index, has provided a total return of 339% with an annualised return of 5.7%. A total gain of approximately 3.4x an investment made in March 1999.

 

The success of the Company under Hamish's leadership was recognised in May 2024 when it was reported that the Company was one of only eight investments trusts or funds available to UK investors, managed by the same lead manager for the previous twenty years, which had outperformed Berkshire Hathaway, managed by Warren Buffet.

 

Richard Gray, the Chairman of the Company noted that, "the Board thanks Hamish Mair for his invaluable contribution to the success of the Company and his tireless enthusiasm for the Private Equity sector and the opportunities that it can provide to investors. The Board looks forward with confidence to continuing the Company's success under the management of Andrew Carnwath".

 

Legal Entity Identifier: 2138009FW98WZFCGRN66

 

For more information, please contact:

 

Hamish Mair (Investment Manager)

0131 573 8314

Scott McEllen (Company Secretary)

0131 573 8372

hamish.mair@columbiathreadneedle.com  / scott.mcellen@columbiathreadneedle.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMZMVRKGKZM
Date   Source Headline
24th Sep 20242:37 pmRNSHolding(s) in Company
24th Sep 20242:35 pmRNSDirector Declaration
2nd Sep 202410:00 amRNSTotal Voting Rights
29th Aug 20247:00 amRNSInterim Results and dividend Announcement
1st Aug 20241:31 pmRNSTotal Voting Rights
1st Jul 20249:51 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSDirector Declaration
3rd Jun 202412:03 pmRNSTotal Voting Rights
29th May 20243:24 pmRNSResults of AGM and Directorate Change
29th May 202411:51 amRNS1st Quarter Results and Dividend Announcement
15th May 20247:00 amRNSKepler Trust Intelligence: New Research
2nd May 20245:27 pmRNSTransaction in Own Shares
2nd May 20244:58 pmRNSHolding(s) in Company
1st May 20249:43 amRNSTotal Voting Rights
29th Apr 20243:08 pmRNSDirector/PDMR Shareholding
26th Apr 20245:08 pmRNSDirector/PDMR Shareholding
16th Apr 20244:22 pmRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSAnnual Financial Report
8th Apr 20249:08 amRNSTransaction in Own Shares
3rd Apr 20241:11 pmRNSDirector/PDMR Shareholding
3rd Apr 20247:00 amRNSPreliminary Annual Results and Quarterly Dividend
2nd Apr 202411:53 amRNSInvestor Presentation
2nd Apr 202410:36 amRNSTotal Voting Rights
1st Mar 20249:16 amRNSTotal Voting Rights
1st Feb 202411:18 amRNSTotal Voting Rights
2nd Jan 20249:14 amRNSTotal Voting Rights
20th Dec 20239:53 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSKepler Trust Intelligence: New Research
19th Dec 20237:00 amRNSDirectorate Change
8th Dec 202312:01 pmRNSTransaction in Own Shares
1st Dec 202310:19 amRNSTotal Voting Rights
30th Nov 20233:32 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNS3rd Quarter Results and Dividend announcement
13th Nov 20239:42 amRNSInvestor Presentation
1st Nov 20239:52 amRNSTotal Voting Rights
31st Oct 202311:39 amRNSMajor Shareholding Notifications
17th Oct 202310:01 amRNSMajor Shareholding Notifications
2nd Oct 20239:30 amRNSTotal Voting Rights
1st Sep 20239:23 amRNSTotal Voting Rights
23rd Aug 20237:00 amRNSHalf-year Report
7th Aug 202310:58 amRNSInvestor Presentation
1st Aug 20239:44 amRNSTotal Voting Rights
3rd Jul 202311:27 amRNSTotal Voting Rights
6th Jun 20237:00 amRNSKepler Trust Intelligence: New Research
1st Jun 20239:57 amRNSTotal Voting Rights
26th May 20232:54 pmRNSDirector/PDMR Shareholding
24th May 20233:25 pmRNSDirector Declaration
23rd May 20234:52 pmRNSAnnual General Meeting and Retirement of Director
23rd May 202311:30 amRNSQuarterly net asset value and dividend
2nd May 202310:51 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.